BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24108698)

  • 1. A distinct subpopulation of human NK cells restricts B cell transformation by EBV.
    Lünemann A; Vanoaica LD; Azzi T; Nadal D; Münz C
    J Immunol; 2013 Nov; 191(10):4989-95. PubMed ID: 24108698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.
    Jud A; Kotur M; Berger C; Gysin C; Nadal D; Lünemann A
    Oncotarget; 2017 Jan; 8(4):6130-6141. PubMed ID: 28008151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma.
    Strowig T; Brilot F; Arrey F; Bougras G; Thomas D; Muller WA; Münz C
    PLoS Pathog; 2008 Feb; 4(2):e27. PubMed ID: 18266470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
    Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
    Front Immunol; 2020; 11():1231. PubMed ID: 32625211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus.
    Hendricks DW; Balfour HH; Dunmire SK; Schmeling DO; Hogquist KA; Lanier LL
    J Immunol; 2014 May; 192(10):4492-6. PubMed ID: 24740502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
    Wilson AD; Morgan AJ
    J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine activation induces human memory-like NK cells.
    Romee R; Schneider SE; Leong JW; Chase JM; Keppel CR; Sullivan RP; Cooper MA; Fehniger TA
    Blood; 2012 Dec; 120(24):4751-60. PubMed ID: 22983442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.
    Yu J; Mao HC; Wei M; Hughes T; Zhang J; Park IK; Liu S; McClory S; Marcucci G; Trotta R; Caligiuri MA
    Blood; 2010 Jan; 115(2):274-81. PubMed ID: 19897577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disordered expression of inhibitory receptors on the NK1-type natural killer (NK) leukaemic cells from patients with hypersensitivity to mosquito bites.
    Seo N; Tokura Y; Ishihara S; Takeoka Y; Tagawa S; Takigawa M
    Clin Exp Immunol; 2000 Jun; 120(3):413-9. PubMed ID: 10844517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells.
    Djaoud Z; Guethlein LA; Horowitz A; Azzi T; Nemat-Gorgani N; Olive D; Nadal D; Norman PJ; Münz C; Parham P
    J Exp Med; 2017 Jun; 214(6):1827-1841. PubMed ID: 28468758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK cells eliminate Epstein-Barr virus bound to B cells through a specific antibody-mediated uptake.
    Alari-Pahissa E; Ataya M; Moraitis I; Campos-Ruiz M; Altadill M; Muntasell A; Moles A; López-Botet M
    PLoS Pathog; 2021 Aug; 17(8):e1009868. PubMed ID: 34415956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.
    Tsuge I; Morishima T; Kimura H; Kuzushima K; Matsuoka H
    J Med Virol; 2001 Jun; 64(2):141-8. PubMed ID: 11360246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on expression of natural killer (NK) cell C-type lectin-like receptors in nasal NK/T-cell lymphomas].
    Nong L; Zhang S; Li Y; Zhang Y; Wang Y; Li T
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):319-24. PubMed ID: 20654155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for early-differentiated natural killer cells in infectious mononucleosis.
    Azzi T; Lünemann A; Murer A; Ueda S; Béziat V; Malmberg KJ; Staubli G; Gysin C; Berger C; Münz C; Chijioke O; Nadal D
    Blood; 2014 Oct; 124(16):2533-43. PubMed ID: 25205117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells.
    MacArthur GJ; Wilson AD; Birchall MA; Morgan AJ
    J Virol; 2007 May; 81(9):4766-75. PubMed ID: 17314172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.
    Ferlazzo G; Thomas D; Lin SL; Goodman K; Morandi B; Muller WA; Moretta A; Münz C
    J Immunol; 2004 Feb; 172(3):1455-62. PubMed ID: 14734722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ.
    Sohlberg E; Saghafian-Hedengren S; Rasul E; Marchini G; Nilsson C; Klein E; Nagy N; Sverremark-Ekström E
    J Immunol; 2013 Dec; 191(11):5669-76. PubMed ID: 24140645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD.
    Wiesmayr S; Webber SA; Macedo C; Popescu I; Smith L; Luce J; Metes D
    Eur J Immunol; 2012 Feb; 42(2):541-50. PubMed ID: 22105417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells.
    Morandi F; Ferretti E; Castriconi R; Dondero A; Petretto A; Bottino C; Pistoia V
    Blood; 2011 Nov; 118(22):5840-50. PubMed ID: 21989990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.
    Korbel DS; Norman PJ; Newman KC; Horowitz A; Gendzekhadze K; Parham P; Riley EM
    J Immunol; 2009 May; 182(10):6426-34. PubMed ID: 19414796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.